Comprehensive Assessment of Immuno-oncology Biomarkers in Adenocarcinoma, Urothelial Carcinoma, and Squamous-cell Carcinoma of the Bladder

In patients with rare histologies of bladder cancer, including adenocarcinoma of the bladder (ACB) and squamous-cell carcinoma (SCC), there are limited standard therapy options, defining an unmet medical need. In this comparative comprehensive genomic profiling (CGP) study, genomic alterations (GAs)...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	European urology 2020-04, Vol.77 (4), p.548-556
Hauptverfasser:	Necchi, Andrea, Madison, Russell, Raggi, Daniele, Jacob, Joseph M., Bratslavsky, Gennady, Shapiro, Oleg, Elvin, Julia A., Vergilio, Jo-Anne, Killian, Jonathan K., Ngo, Nhu, Ramkissoon, Shakti, Severson, Eric, Hemmerich, Amanda C., Huang, Richard, Ali, Siraj M., Chung, Jon H., Reddy, Prasanth, Miller, Vincent A., Schrock, Alexa B., Gay, Laurie M., Alexander, Brian M., Grivas, Petros, Ross, Jeffrey S.
Format:	Artikel
Sprache:	eng
Schlagworte:	Bladder adenocarcinoma Bladder squamous-cell carcinoma Genomic alterations Immunotherapy biomarkers Variant histologies
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!